Introduction: A Decade of Policy Divergence More than a decade after the Affordable Care Act (ACA) was...
Written by Douglas Feil, NBCF Chief Program Officer Disclaimer: The information provided in this article is for...
HOUSTON – In a landmark development for the field of reconstructive and aesthetic medicine, Lynn A. Damitz,...
The intersection of artificial intelligence and pharmaceutical development has long been framed as the next frontier of...
In a move signaling a major shift in how the U.S. regulatory body evaluates life-saving treatments, the...
NEW YORK, NY — As Breast Cancer Awareness Month unfolds each October, the skyline of the world...
Introduction: The Erosion of a Decades-Long Partnership The relationship between the United States of America and the...
To the average observer, the narrative surrounding breast cancer is overwhelmingly gendered. From the pink ribbons that...
Oklahoma City, OK – In a significant stride for cancer research, scientists at the University of Oklahoma...
A pioneering investigational therapy, MGC030, developed by US-based biopharmaceutical company MacroGenics, has reached a significant milestone with...
